{"title":"Adalimumab","summary":"Adalimumab, is a disease-modifying antirheumatic drug and monoclonal antibody that works by inactivating tumor necrosis factor-alpha (TNFÎ±).[5] It is sold under the brand name Humira, among others. It is a medication used to treat rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, psoriasis, hidradenitis suppurativa, uveitis, and juvenile idiopathic arthritis.[6][7][8] Use is generally only recommended in people who have not responded to other treatments.[7] It is administered by injection under the skin.[6]","image":"Adalimumab_structure.svg.png.webp","url":"Adalimumab"}